169 related articles for article (PubMed ID: 31916450)
1. Cell-free circulating epimarks in cancer monitoring.
Duforestel M; Briand J; Bougras-Cartron G; Heymann D; Frenel JS; Vallette FM; Cartron PF
Epigenomics; 2020 Jan; 12(2):145-155. PubMed ID: 31916450
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of circulating non-coding RNAs - an update.
Anfossi S; Babayan A; Pantel K; Calin GA
Nat Rev Clin Oncol; 2018 Sep; 15(9):541-563. PubMed ID: 29784926
[TBL] [Abstract][Full Text] [Related]
3. Circulating Noncoding RNAs Have a Promising Future Acting as Novel Biomarkers for Colorectal Cancer.
Wang JJ; Wang X; Song YX; Zhao JH; Sun JX; Shi JX; Wu ZH; Wang ZN
Dis Markers; 2019; 2019():2587109. PubMed ID: 31275444
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific methylations in circulating cell-free DNA as clinically applicable markers with potential to substitute mutational analyses.
Andersen RF
Expert Rev Mol Diagn; 2018 Dec; 18(12):1011-1019. PubMed ID: 30411633
[No Abstract] [Full Text] [Related]
5. Long Noncoding RNAs as Biomarkers in Cancer.
Bolha L; Ravnik-Glavač M; Glavač D
Dis Markers; 2017; 2017():7243968. PubMed ID: 28634418
[TBL] [Abstract][Full Text] [Related]
6. Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma.
Tan C; Cao J; Chen L; Xi X; Wang S; Zhu Y; Yang L; Ma L; Wang D; Yin J; Zhang T; John Lu Z
Clin Chem; 2019 Jul; 65(7):905-915. PubMed ID: 30996051
[TBL] [Abstract][Full Text] [Related]
7. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
Junqueira-Neto S; Batista IA; Costa JL; Melo SA
Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
[TBL] [Abstract][Full Text] [Related]
9. Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics.
Fedyuk V; Erez N; Furth N; Beresh O; Andreishcheva E; Shinde A; Jones D; Zakai BB; Mavor Y; Peretz T; Hubert A; Cohen JE; Salah A; Temper M; Grinshpun A; Maoz M; Zick A; Ron G; Shema E
Nat Biotechnol; 2023 Feb; 41(2):212-221. PubMed ID: 36076083
[TBL] [Abstract][Full Text] [Related]
10. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
11. 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.
Song CX; Yin S; Ma L; Wheeler A; Chen Y; Zhang Y; Liu B; Xiong J; Zhang W; Hu J; Zhou Z; Dong B; Tian Z; Jeffrey SS; Chua MS; So S; Li W; Wei Y; Diao J; Xie D; Quake SR
Cell Res; 2017 Oct; 27(10):1231-1242. PubMed ID: 28820176
[TBL] [Abstract][Full Text] [Related]
12. Cell-free DNA in blood as a noninvasive insight into the sarcoma genome.
Namløs HM; Boye K; Meza-Zepeda LA
Mol Aspects Med; 2020 Apr; 72():100827. PubMed ID: 31703948
[TBL] [Abstract][Full Text] [Related]
13. The functional roles of exosomes-derived long non-coding RNA in human cancer.
Chen F; Wang N; Tan HY; Guo W; Zhang C; Feng Y
Cancer Biol Ther; 2019; 20(5):583-592. PubMed ID: 30739532
[TBL] [Abstract][Full Text] [Related]
14. A high-throughput protocol for isolating cell-free circulating tumor DNA from peripheral blood.
Pandoh PK; Corbett RD; McDonald H; Alcaide M; Kirk H; Trinh E; Haile S; MacLeod T; Smailus D; Bilobram S; Mungall AJ; Ma Y; Moore RA; Coope R; Zhao Y; Jones SJ; Holt RA; Karsan A; Morin RD; Marra MA
Biotechniques; 2019 Feb; 66(2):85-92. PubMed ID: 30744412
[TBL] [Abstract][Full Text] [Related]
15. Genetic profiling of cancer with circulating tumor DNA analysis.
Lu L; Bi J; Bao L
J Genet Genomics; 2018 Feb; 45(2):79-85. PubMed ID: 29502957
[TBL] [Abstract][Full Text] [Related]
16. Known epigenetic biomarkers for prostate cancer detection and management: exploring the potential of blood-based liquid biopsies.
Constâncio V; Barros-Silva D; Jerónimo C; Henrique R
Expert Rev Mol Diagn; 2019 May; 19(5):367-375. PubMed ID: 30961397
[TBL] [Abstract][Full Text] [Related]
17. Sensitive tumour detection and classification using plasma cell-free DNA methylomes.
Shen SY; Singhania R; Fehringer G; Chakravarthy A; Roehrl MHA; Chadwick D; Zuzarte PC; Borgida A; Wang TT; Li T; Kis O; Zhao Z; Spreafico A; Medina TDS; Wang Y; Roulois D; Ettayebi I; Chen Z; Chow S; Murphy T; Arruda A; O'Kane GM; Liu J; Mansour M; McPherson JD; O'Brien C; Leighl N; Bedard PL; Fleshner N; Liu G; Minden MD; Gallinger S; Goldenberg A; Pugh TJ; Hoffman MM; Bratman SV; Hung RJ; De Carvalho DD
Nature; 2018 Nov; 563(7732):579-583. PubMed ID: 30429608
[TBL] [Abstract][Full Text] [Related]
18. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
[TBL] [Abstract][Full Text] [Related]
19. Investors keep the faith in cancer liquid biopsies.
Sheridan C
Nat Biotechnol; 2019 Sep; 37(9):972-974. PubMed ID: 31485041
[No Abstract] [Full Text] [Related]
20. Potential clinical applications of circulating cell-free DNA in ovarian cancer patients.
Barbosa A; Peixoto A; Pinto P; Pinheiro M; Teixeira MR
Expert Rev Mol Med; 2018 Dec; 20():e6. PubMed ID: 30558693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]